MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company ...
Puma Biotechnology (NASDAQ:PBYI) reported fourth-quarter 2025 total revenue of $75.5 million, driven by NERLYNX product ...
COPENHAGEN, Feb 24 (Reuters) - Novo Nordisk said on Tuesday its triple agonist UBT251 of the receptors for GLP-1, GIP and ...
With our Phase IIa program underway and defined milestones in front of us, we look forward to engaging with investors and potential partners at BIO.” — Christer Rosén, Chairman and Chief Executive ...
Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced ...
We are talking about synthetic blood, for example for treating the wounded without the need to refrigerate and transport ...
UniQure said Monday that plans to seek approval for its Huntington’s disease treatment with the Food and Drug Administration ...
BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company ...
A professional in the event planning division of an international biotechnology trade group is running as a Democrat for the District 1 County Council seat, with a focus on data center ...
Astellas Pharma Inc. and Vir Biotechnology, Inc. have entered into a global strategic collaboration to advance VIR-5500, an ...
Rallybio has inked a deal to combine with fellow clinical-stage biotechnology company Candid Therapeutics in an all-stock reverse merger. Rallybio on Monday said its shareholders will own about 3.65% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results